CA1063132A - 4,5-dialkoxy-(6),7-indanaldehyde - Google Patents
4,5-dialkoxy-(6),7-indanaldehydeInfo
- Publication number
- CA1063132A CA1063132A CA303,560A CA303560A CA1063132A CA 1063132 A CA1063132 A CA 1063132A CA 303560 A CA303560 A CA 303560A CA 1063132 A CA1063132 A CA 1063132A
- Authority
- CA
- Canada
- Prior art keywords
- dialkoxy
- dimethoxy
- indanaldehyde
- acid
- cyclopentano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 16
- 150000001299 aldehydes Chemical class 0.000 claims description 12
- CKKAOFMMFNPZPR-UHFFFAOYSA-N 6,7-dimethoxy-2,3-dihydro-1h-indene-5-carbaldehyde Chemical compound O=CC1=C(OC)C(OC)=C2CCCC2=C1 CKKAOFMMFNPZPR-UHFFFAOYSA-N 0.000 claims description 6
- KHVRKYOQRGQIRY-UHFFFAOYSA-N 6,7-dimethoxy-2,3-dihydro-1h-indene-4-carbaldehyde Chemical compound COC1=CC(C=O)=C2CCCC2=C1OC KHVRKYOQRGQIRY-UHFFFAOYSA-N 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 4
- 238000005727 Friedel-Crafts reaction Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 235000013350 formula milk Nutrition 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 13
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 6
- 239000001257 hydrogen Substances 0.000 abstract description 6
- 239000000543 intermediate Substances 0.000 abstract description 6
- 150000003839 salts Chemical class 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- CMKDJMDGRSJZIS-UHFFFAOYSA-N 2,3-dihydro-1h-indene-1-carbaldehyde Chemical class C1=CC=C2C(C=O)CCC2=C1 CMKDJMDGRSJZIS-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003276 anti-hypertensive effect Effects 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 18
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 18
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 9
- -1 nitrovinyl compound Chemical class 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- HWTJUAINQVAQDN-UHFFFAOYSA-N 2-(6,7-dimethoxy-2,3-dihydro-1h-inden-5-yl)ethanamine Chemical compound NCCC1=C(OC)C(OC)=C2CCCC2=C1 HWTJUAINQVAQDN-UHFFFAOYSA-N 0.000 description 5
- OYPVPAXDSIDUQG-UHFFFAOYSA-N 4,5-dimethoxy-2,3-dihydro-1h-indene Chemical compound COC1=CC=C2CCCC2=C1OC OYPVPAXDSIDUQG-UHFFFAOYSA-N 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- MGFREDWKELGWML-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinolin-2-ium;chloride Chemical compound [Cl-].C1=CC=C2C[NH2+]CCC2=C1 MGFREDWKELGWML-UHFFFAOYSA-N 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- 239000005695 Ammonium acetate Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 235000019257 ammonium acetate Nutrition 0.000 description 4
- 229940043376 ammonium acetate Drugs 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 3
- ITDHODBHQNVRFW-UHFFFAOYSA-N 4,5-dimethoxy-6-(2-nitroethenyl)-2,3-dihydro-1h-indene Chemical compound [O-][N+](=O)C=CC1=C(OC)C(OC)=C2CCCC2=C1 ITDHODBHQNVRFW-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000011260 aqueous acid Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- CPNJBAMJTFVFFF-UHFFFAOYSA-N 4,5-dimethoxy-7-(2-nitroethenyl)-2,3-dihydro-1h-indene Chemical compound COC1=CC(C=C[N+]([O-])=O)=C2CCCC2=C1OC CPNJBAMJTFVFFF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 229910010084 LiAlH4 Inorganic materials 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000004971 nitroalkyl group Chemical group 0.000 description 2
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- QVJWNNLGNDQMMY-UHFFFAOYSA-N 1-(6,7-diethoxy-2,3-dihydro-1h-inden-4-yl)propan-2-amine Chemical compound CCOC1=CC(CC(C)N)=C2CCCC2=C1OCC QVJWNNLGNDQMMY-UHFFFAOYSA-N 0.000 description 1
- VZJSCBVJXIHTIY-UHFFFAOYSA-N 1-(6,7-diethoxy-2,3-dihydro-1h-inden-5-yl)propan-2-amine Chemical compound CC(N)CC1=C(OCC)C(OCC)=C2CCCC2=C1 VZJSCBVJXIHTIY-UHFFFAOYSA-N 0.000 description 1
- ATYVGMRNNKLFFA-UHFFFAOYSA-N 1-(6,7-dipropoxy-2,3-dihydro-1h-inden-4-yl)butan-2-amine Chemical compound CCCOC1=CC(CC(N)CC)=C2CCCC2=C1OCCC ATYVGMRNNKLFFA-UHFFFAOYSA-N 0.000 description 1
- SECAQUZEXAHWBA-UHFFFAOYSA-N 1-ethyl-2,3-dihydro-1h-indene Chemical compound C1=CC=C2C(CC)CCC2=C1 SECAQUZEXAHWBA-UHFFFAOYSA-N 0.000 description 1
- VNWQQFOZEKADBU-UHFFFAOYSA-N 2-(6,7-dimethoxy-2,3-dihydro-1h-inden-4-yl)ethanamine Chemical compound COC1=CC(CCN)=C2CCCC2=C1OC VNWQQFOZEKADBU-UHFFFAOYSA-N 0.000 description 1
- WFYSSTHMJYADMI-UHFFFAOYSA-N 2-(6-ethoxy-7-methoxy-2,3-dihydro-1h-inden-4-yl)ethanamine Chemical compound CCOC1=CC(CCN)=C2CCCC2=C1OC WFYSSTHMJYADMI-UHFFFAOYSA-N 0.000 description 1
- YNMDENKWNSWIEE-UHFFFAOYSA-N 2-(6-ethoxy-7-methoxy-2,3-dihydro-1h-inden-5-yl)ethanamine Chemical compound CCOC1=C(CCN)C=C2CCCC2=C1OC YNMDENKWNSWIEE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ACUKSMLNQJTHEL-UHFFFAOYSA-N 4,5-di(propan-2-yloxy)-2,3-dihydro-1h-indene Chemical compound CC(C)OC1=CC=C2CCCC2=C1OC(C)C ACUKSMLNQJTHEL-UHFFFAOYSA-N 0.000 description 1
- RIHNBVJSAXNNLW-UHFFFAOYSA-N 4,5-diethoxy-2,3-dihydro-1h-indene Chemical compound CCOC1=CC=C2CCCC2=C1OCC RIHNBVJSAXNNLW-UHFFFAOYSA-N 0.000 description 1
- JQXASNXFUUDUDW-UHFFFAOYSA-N 4,5-diethoxy-7-(2-nitroethenyl)-2,3-dihydro-1h-indene Chemical compound CCOC1=CC(C=C[N+]([O-])=O)=C2CCCC2=C1OCC JQXASNXFUUDUDW-UHFFFAOYSA-N 0.000 description 1
- XQODIRIVQXQUFN-UHFFFAOYSA-N 4,5-dimethoxy-2,3-dihydroinden-1-one Chemical compound COC1=CC=C2C(=O)CCC2=C1OC XQODIRIVQXQUFN-UHFFFAOYSA-N 0.000 description 1
- INBAOLFKFLYIAV-UHFFFAOYSA-N 4,5-dimethoxy-7-(2-nitroprop-1-enyl)-2,3-dihydro-1h-indene Chemical compound COC1=CC(C=C(C)[N+]([O-])=O)=C2CCCC2=C1OC INBAOLFKFLYIAV-UHFFFAOYSA-N 0.000 description 1
- IKLVFVLEUXKOTQ-UHFFFAOYSA-N 4,5-dipropoxy-2,3-dihydro-1h-indene Chemical compound CCCOC1=CC=C2CCCC2=C1OCCC IKLVFVLEUXKOTQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KZIMLUFVKJLCCH-UHFFFAOYSA-N 5-[2-(1h-imidazol-5-yl)ethylamino]-5-oxopentanoic acid Chemical compound OC(=O)CCCC(=O)NCCC1=CNC=N1 KZIMLUFVKJLCCH-UHFFFAOYSA-N 0.000 description 1
- CNDZXXYCHQSGOA-UHFFFAOYSA-N 5-ethoxy-4-methoxy-2,3-dihydro-1h-indene Chemical compound CCOC1=CC=C2CCCC2=C1OC CNDZXXYCHQSGOA-UHFFFAOYSA-N 0.000 description 1
- HOEQJFXFNVLWPC-UHFFFAOYSA-N 5-ethoxy-4-methoxy-2,3-dihydroinden-1-one Chemical compound CCOC1=CC=C2C(=O)CCC2=C1OC HOEQJFXFNVLWPC-UHFFFAOYSA-N 0.000 description 1
- IFNMBDQOCFKGTH-UHFFFAOYSA-N 6,7-diethoxy-2,3-dihydro-1h-indene-5-carbaldehyde Chemical compound O=CC1=C(OCC)C(OCC)=C2CCCC2=C1 IFNMBDQOCFKGTH-UHFFFAOYSA-N 0.000 description 1
- SDDAMBBSWPIUQV-UHFFFAOYSA-N 6,7-dipropoxy-2,3-dihydro-1h-indene-5-carbaldehyde Chemical compound O=CC1=C(OCCC)C(OCCC)=C2CCCC2=C1 SDDAMBBSWPIUQV-UHFFFAOYSA-N 0.000 description 1
- KIIWVZOLVPGIQD-UHFFFAOYSA-N 6-ethoxy-7-methoxy-2,3-dihydro-1h-indene-4-carbaldehyde Chemical compound CCOC1=CC(C=O)=C2CCCC2=C1OC KIIWVZOLVPGIQD-UHFFFAOYSA-N 0.000 description 1
- XTGBVZHKRAHHIP-UHFFFAOYSA-N 6-ethoxy-7-methoxy-2,3-dihydro-1h-indene-5-carbaldehyde Chemical compound CCOC1=C(C=O)C=C2CCCC2=C1OC XTGBVZHKRAHHIP-UHFFFAOYSA-N 0.000 description 1
- ASZRFUOPBLFHEA-UHFFFAOYSA-N 7-(2-nitroethenyl)-4,5-dipropoxy-2,3-dihydro-1h-indene Chemical compound CCCOC1=CC(C=C[N+]([O-])=O)=C2CCCC2=C1OCCC ASZRFUOPBLFHEA-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FKCBLVCOSCZFHV-UHFFFAOYSA-N acetonitrile;ethanol Chemical compound CCO.CC#N FKCBLVCOSCZFHV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 229930189585 ingamine Natural products 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- KRTCNRRLJANNSH-UHFFFAOYSA-N n-[1-(6,7-dipropoxy-2,3-dihydro-1h-inden-4-yl)butan-2-yl]methanimine Chemical compound CCCOC1=CC(CC(CC)N=C)=C2CCCC2=C1OCCC KRTCNRRLJANNSH-UHFFFAOYSA-N 0.000 description 1
- ORYHODJWDKTVSD-UHFFFAOYSA-N n-[1-(6,7-dipropoxy-2,3-dihydro-1h-inden-5-yl)butan-2-yl]methanimine Chemical compound CCC(N=C)CC1=C(OCCC)C(OCCC)=C2CCCC2=C1 ORYHODJWDKTVSD-UHFFFAOYSA-N 0.000 description 1
- WQJWIMOQQFIBOM-UHFFFAOYSA-N n-[2-(6,7-dimethoxy-2,3-dihydro-1h-inden-4-yl)ethyl]methanimine Chemical compound COC1=CC(CCN=C)=C2CCCC2=C1OC WQJWIMOQQFIBOM-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA303,560A CA1063132A (fr) | 1974-03-28 | 1978-05-17 | 4,5-dialkoxy-(6),7-indanaldehyde |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/455,574 US3963723A (en) | 1974-03-28 | 1974-03-28 | Cyclopentano (h) or (f) 1,2,3,4-tetrahydroisoquinolines |
| CA223,273A CA1063117A (fr) | 1974-03-28 | 1975-03-27 | Cyclopentano (h) ou (f) 1,2,3,4-tetrahydroisoquinolines |
| CA303,560A CA1063132A (fr) | 1974-03-28 | 1978-05-17 | 4,5-dialkoxy-(6),7-indanaldehyde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1063132A true CA1063132A (fr) | 1979-09-25 |
Family
ID=27163879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA303,560A Expired CA1063132A (fr) | 1974-03-28 | 1978-05-17 | 4,5-dialkoxy-(6),7-indanaldehyde |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1063132A (fr) |
-
1978
- 1978-05-17 CA CA303,560A patent/CA1063132A/fr not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3711489A (en) | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles | |
| Gladiali et al. | Optically active phenanthrolines in asymmetric catalysis: II. Enantioselective transfer hydrogenation of acetophenone by rhodium/alkyl phenanthroline catalysts | |
| US4000197A (en) | Asymmetric synthesis of phenylisopropylamines | |
| CA1206476A (fr) | Composes de pyrolidine et de piperidine | |
| EP0028381B1 (fr) | Azépinoindoles, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| EP0061149B1 (fr) | Dérivés du alkylènedioxybenzène et leurs sels d'addition acides et procédé pour leur préparation | |
| PL90293B1 (fr) | ||
| KR840001071B1 (ko) | 9-카바모일-9-(2-시아노에틸)플루오렌유도체의 제조방법 | |
| CA1063132A (fr) | 4,5-dialkoxy-(6),7-indanaldehyde | |
| US4010202A (en) | 5,6-Dihydroxy aminotetralol compounds | |
| Reckhow et al. | Hexahydroindolo [2, 3-a] quinolizine1 | |
| FR2495470A1 (fr) | Nouveaux medicaments a base de derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanol ou (quinolyl-4)-1 (piperidyl-4)-3 propanol | |
| IL25953A (en) | Phenanthridine derivatives and process for the manufacture thereof | |
| CA1063117A (fr) | Cyclopentano (h) ou (f) 1,2,3,4-tetrahydroisoquinolines | |
| US4705807A (en) | Amine derivatives | |
| US3997608A (en) | N-substituted-dihydroxyphenethylamines | |
| US4071562A (en) | 4,5-Dialkoxy-6 or 7-indanaldehydes | |
| US4059586A (en) | 5-Alkoxy-2-alkyl-1,2,3,4-tetrahydroisoquinolene-8-carboxaldehyde and derivatives | |
| JPS5849369A (ja) | 新規のイミダゾール化合物 | |
| LEONARD et al. | Synthesis of 2-Hydroxymethylquinolizidine (dl-2-Lupinine) | |
| CA1123826A (fr) | Cetoamines cycloaliphatiques | |
| CA2011461A1 (fr) | Derives de tetrahydronaphthalene | |
| CA1061791A (fr) | 7,8-dihydroxy-cyclopentano(f)-1,2,3,4-tetrahydroisoquinolines a substituants en n et ses derives ethers et esters | |
| US3953458A (en) | 1-Substituted amino-2-alkyl-5-hydroxy-7,8-cyclopentano[h]-1,2,3,4-tetrahydroisoquinolines | |
| US3962254A (en) | N-substituted-5,6-dihydroxycyclopentano[h]-1,2,3,4-tetrahydroisoquinolines and ethers and esters thereof |